Indira IVF in talks to acquire 75% stake in Kerala’s Sabine Hospital for Rs.1,300-Cr

Udaipur, Rajasthan-headquartered fertility clinic chain Indira IVF is in talks to acquire a 70-75% stake in Kerala-based Sabine Hospital and Research Centre , at an enterprise valuation between INR 1,200-Cr and INR 1,300-Cr. Indira IVF may also purchase additional shares from the founder. O3 Capital is acting as the advisor to CX Partners regarding its exit from the Sabine investment.Founded in 2010 by Dr. Sabine Sivadasan, Sabine Hospital provides fertility treatments, birthing services, newborn care, and other gynaecological procedures across two facilities in Kerala with a combined capacity of 300 beds. The company claims to conduct over 6,000 IVF cycles and 3,000 deliveries annually and is expected to generate revenue between INR 230-Cr and INR 250-Cr in FY27.Indira IVF is currently preparing for an initial public offering of INR 3,500-Cr. It has completed several acquisitions in the fertility space over the past few years, including Abha Surgy Healthcare, Creation Science IVF, and Banker IVF.